These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 32570732

  • 21. Plasminogen activator inhibitor-1 4G4G genotype is associated with myocardial infarction but not with stable coronary artery disease.
    Onalan O, Balta G, Oto A, Kabakci G, Tokgozoglu L, Aytemir K, Altay C, Gurgey A, Nazli N.
    J Thromb Thrombolysis; 2008 Dec; 26(3):211-7. PubMed ID: 17721742
    [Abstract] [Full Text] [Related]

  • 22. The Association of Plasminogen Activator Inhibitor Type 1 (PAI-1) Level and PAI-1 4G/5G Gene Polymorphism with the Formation and the Grade of Endometrial Cancer.
    Yıldırım ME, Karakuş S, Kurtulgan HK, Kılıçgün H, Erşan S, Bakır S.
    Biochem Genet; 2017 Aug; 55(4):314-321. PubMed ID: 28303356
    [Abstract] [Full Text] [Related]

  • 23. Role of the tissue-type plasminogen activator -7351C > T and plasminogen activator inhibitor 1 4G/5G gene polymorphisms in central serous chorioretinopathy.
    Malle EM, Posch-Pertl L, Renner W, Pinter-Hausberger S, Singer C, Haas A, Wedrich A, Weger M.
    Ophthalmic Genet; 2018 Dec; 39(6):714-716. PubMed ID: 30442055
    [Abstract] [Full Text] [Related]

  • 24. 4G/5G and A-844G Polymorphisms of Plasminogen Activator Inhibitor-1 Associated with Glioblastoma in Iran--a Case-Control Study.
    Pooyan H, Ahmad E, Azadeh R.
    Asian Pac J Cancer Prev; 2015 Dec; 16(15):6327-30. PubMed ID: 26434837
    [Abstract] [Full Text] [Related]

  • 25. Association Between Plasminogen Activator Inhibitor-1 Genetic Polymorphisms and Stroke Susceptibility.
    Hu X, Zan X, Xie Z, Li Y, Lin S, Li H, You C.
    Mol Neurobiol; 2017 Jan; 54(1):328-341. PubMed ID: 26742513
    [Abstract] [Full Text] [Related]

  • 26. Plasminogen activator inhibitor type-1 (PAI-1) polymorphism 4G/5G is associated with prostate cancer among men with a positive family history.
    Jorgenson E, Deitcher SR, Cicek M, Liu X, Plummer S, Casey G, Witte JS.
    Prostate; 2007 Feb 01; 67(2):172-7. PubMed ID: 17044080
    [Abstract] [Full Text] [Related]

  • 27. The influence of 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene promoter on the incidence, growth and operative risk of abdominal aortic aneurysm.
    Jones K, Powell J, Brown L, Greenhalgh R, Jormsjö S, Eriksson P.
    Eur J Vasc Endovasc Surg; 2002 May 01; 23(5):421-5. PubMed ID: 12027469
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Plasminogen activator inhibitor-1 4G/5G and the MTHFR 677C/T polymorphisms and susceptibility to polycystic ovary syndrome: a meta-analysis.
    Lee YH, Song GG.
    Eur J Obstet Gynecol Reprod Biol; 2014 Apr 01; 175():8-14. PubMed ID: 24439532
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Plasminogen activator inhibitor-1 promoter sequence variations in idiopathic osteonecrosis of head of femur.
    Raman S, Dada R, Nag TC, Yadav CS.
    Indian J Med Res; 2021 Jun 01; 154(6):849-856. PubMed ID: 35662090
    [Abstract] [Full Text] [Related]

  • 32. Plasminogen activator inhibitor I 4G/5G polymorphism in neonatal respiratory distress syndrome.
    Armangil D, Yurdakök M, Okur H, Gürgey A.
    Clin Appl Thromb Hemost; 2011 Aug 01; 17(4):352-7. PubMed ID: 20460339
    [Abstract] [Full Text] [Related]

  • 33. [Relationship between polymorphisms of plasminogen activator inhibitor-1 promoter gene and pulmonary thromboembolism in Chinese Han population].
    Zhai ZG, Wang C, Yang YH, Pang BS, Xiao B, Liu YM, Mao YL, Weng XZ.
    Zhonghua Yi Xue Za Zhi; 2006 May 23; 86(19):1313-7. PubMed ID: 16796899
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Investigation of Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G promoter polymorphism in Indian venous thrombosis patients: A case-control study.
    Prabhudesai A, Shetty S, Ghosh K, Kulkarni B.
    Eur J Haematol; 2017 Sep 23; 99(3):249-254. PubMed ID: 28561456
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Genetic polymorphism of urokinase-type plasminogen activator is interacting with plasminogen activator inhibitor-1 to raise risk of cervical neoplasia.
    Tee YT, Wang PH, Tsai HT, Lin LY, Lin HT, Yang SF, Hsieh YH, Ying TH.
    J Surg Oncol; 2012 Aug 01; 106(2):204-8. PubMed ID: 22354580
    [Abstract] [Full Text] [Related]

  • 40. Genetic polymorphisms at FCER1B and PAI-1 and asthma susceptibility.
    Hizawa N, Maeda Y, Konno S, Fukui Y, Takahashi D, Nishimura M.
    Clin Exp Allergy; 2006 Jul 01; 36(7):872-6. PubMed ID: 16839401
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.